Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADP-ribosylation factor 6 (Arf6) regulatory proteins are a specialized group of enzymes that control the activity of the Arf6 GTPase, a key regulator of membrane trafficking and actin dynamics at the cell periphery (Casanova, 2007). This group primarily consists of Guanine Nucleotide Exchange Factors (GEFs), such as the cytohesin and EFA6 families, which activate Arf6 by promoting the exchange of GDP for GTP, and GTPase-Activating Proteins (GAPs), such as the ACAP and GIT families, which return Arf6 to its inactive GDP-bound state (D'Souza-Schorey & Chavrier, 2006). These regulators are critical for processes including endocytosis, exocytosis, and cell migration, making them pivotal in physiological signaling. In disease contexts, overactivation of Arf6 by its GEFs is frequently associated with cancer metastasis, tumor invasion, and pathological angiogenesis (Li et al., 2017). Pharmacological intervention often targets the GEFs; for instance, the small molecule SecinH3 inhibits the cytohesin family of GEFs, thereby blocking Arf6 activation and reducing tumor growth in experimental models (Hafner et al., 2006). Additionally, inhibitors like NAV-2729 have been developed to disrupt the interaction between Arf6 and its regulatory GEFs to treat conditions like uveal melanoma and diabetic retinopathy (Yoo et al., 2016).
Inhibition of guanine nucleotide exchange factor (GEF) activity to prevent Arf6 activation or modulation of GTPase-activating protein (GAP) activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor 6 regulatory protein (Arf6 regulatory protein).